TEVA PHARMACEUTICALS, USA, INC., a foreign Profit Company | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TEVA PHARMACEUTICALS, USA, INC., a foreign Profit Company

Sort by

Viewing results 1‒25 of 318

The Big Read
The world’s broken market for medicines
...Caparra was able to secure supplies for her son with the support of a non-profit organisation, Angels for Change, that focuses on drug access....
March 28, 2024
Mizuho Financial Group Inc
Mizuho seeks to break curse over foreign forays on Wall Street
...to record profits....
September 10, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Supply chains
US cancer drug shortage forces doctors to ration life-saving treatments
...The closure in April of a big US generics company Akorn Pharmaceuticals and Teva Pharmaceuticals’ decision last month to trim its generics portfolio highlight the extreme pressure the industry is under,...
June 4, 2023
Johnson & Johnson Co Inc
Johnson & Johnson blames US dollar strength for second cut in profit outlook
...J&J said unfavourable foreign exchange moves would cost the company up to an additional $1.5bn in reported sales this year than it had previously estimated in April....
July 19, 2022
Pharmaceuticals sector
Merck defends tax approach against senator’s claims of avoidance
...Brad Setser, an economist with the Council on Foreign Relations, a non-partisan think-tank, said multiple US pharmaceutical companies report that they earn the vast bulk of profits outside the US despite...
August 7, 2022
News in-depthNeil Shen
Neil Shen’s Sequoia China seeks ‘politically correct’ investment strategy
...“The quick ‘unicorn-making, IPO, profit’ business model is gone,” said the investor in Sequoia China funds....
July 20, 2022
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexNovartis AG
Novartis/Sandoz: selling generics would align Swiss giant with the times Premium content
...That might justify a steeper EV-to-forward ebitda multiple than the seven times commanded by quoted generics companies Teva and Viatris. The unit might fetch at least $15bn, according to Bernstein....
October 26, 2021
News in-depthNikkei Asia
Made in China 2025 plan thrives with subsidies for tech and EV makers
...A version of this article was first published by Nikkei Asia on July 22. ©2022 Nikkei Inc. All rights reserved....
August 1, 2022
Covid-19 vaccines
J&J’s Covid setback risks damaging its vaccine programme
...The rollout pause is likely to have little effect on J&J's first-quarter results, which are due to be announced on Tuesday, since the company is not selling its coronavirus jabs for profit....
April 19, 2021
Moral Money
What chickpeas have to do with PepsiCo’s sustainability push Premium content
...Espen Barth Eide, a former Labour foreign minister told the Financial Times after a centre-left victory for Norway’s Jonas Gahr Store yesterday....
September 15, 2021
South Korean business & finance
South Korea partially lifts short-selling ban
...Investors who break the rules could be imprisoned for at least a year or face financial penalties of up to five times any profit they make on a trade....
February 3, 2021
Moral Money
Japan considers halting support for overseas coal projects Premium content
...policy (FT) Profit or principle is the hard choice for foreign companies in China (FT) UAE listed companies must have at least one female board member: regulator (Reuters) Japan and EU to ally on aid...
March 31, 2021
UK economy
FT economists’ survey: people to feel worse-off as inflation and tax rises bite in 2022
...pay the same tax as small local companies....
January 3, 2022
FT Magazine
Wall Street, bribery and an opioid epidemic: the inside story of a disgraced drugmaker
...There are civil suits against much larger companies including Johnson & Johnson and Teva, as well as distributors and pharmacies....
June 19, 2020
News in-depthThe Big Read
Why growing outcry over harassment threatens South Korea’s cultural push
...profits are often pegged to a single popular act....
September 13, 2020
FT Live
Innovation in Wealth Management Summit
Augmented intelligence for client-centric services
Thursday, 2 May9 Montague Close, London, UK
Due Diligence
IPOs postponed and debt offerings shelved. Coronavirus-induced volatility is gumming up critical sources of capital Premium content
...One scoop to start: law firm Kirkland & Ellis has poached a leading Washington adviser to companies that must navigate secretive US foreign investment and security reviews....
March 4, 2020
News in-depthThe Big Read
How Japan Inc became a target for activist investors
...This remaking of Japan Inc rests on a critical structural shift: the changing role of banks....
February 3, 2020
HSBC Holdings PLC
HSBC sticks by US strategy despite missing targets
...But lower down in the same statement was the news that the bank’s US unit would not hit its target of a 6 per cent return on tangible equity (ROTE) in 2020 — a goal the company set as part of a strategic...
August 8, 2019
News in-depthNikkei Asia
What Japan Inc really thinks about Carlos Ghosn, Nissan’s maverick saviour Premium content
...The system shares company profits with many employees, limiting high rewards at the top level....
January 19, 2020
Merck & Co Inc
Merck profit tops estimates on strong cancer drug sales
...The impact of a stronger US dollar was evident in Merck’s quarterly results, but the pharmaceutical company still managed to report revenue and earnings ahead of Wall Street estimates thanks to strong growth...
February 1, 2019
Merck & Co Inc
Merck raises dividend as cancer drug drives profits
...US pharmaceuticals company Merck has increased its quarterly dividend by 15 per cent and authorised an additional $10bn of treasury stock purchases, as it reaps the rewards of its cancer immunotherapy drug...
October 25, 2018
Due Diligence
When a ‘vulture’ fund comes for the headline writers Premium content
...That’s a question tackled this week in a FT deep dive on Alden, a hedge fund that has made hefty profits by preying upon dying companies and stripping out value....
February 27, 2019
News in-depthThe Big Read
Media: US ‘ghost newspapers’ struggle for life
...It also charges its portfolio companies, such as DFM, fees for managing the business. “It’s just a winding down of the business and taking profits along the way....
February 25, 2019
US politics & policy
Trump blames ‘freeloading’ foreign countries for high drug prices
...companies’ profits....
May 11, 2018
Health
FT Health: Quality not quantity
...Richard Sackler, whose family owns Purdue Pharma, the company behind the notorious painkiller OxyContin, stands to profit from the US opioids epidemic after he patented a new treatment for drug addicts....
September 7, 2018

Previous pagePage 1 of 13Next page